CONTACT
+91 80 2808 2808
info@biocon.com
About Us
Overview
Who we are
Our Key Priorities
Board of Directors
Key Management Team
Our Legacy
Fact Sheet
Our Stories
Scientific Publications
Awards & Recognition
Products
Overview
Key Therapeutic Areas
Generics
Biosimilars
Novel Biologics
Branded Formulations
Businesses
Overview
Generics
Executive Leadership Team
API
Generic Formulations
Quality & Compliance
Manufacturing Operations
Research & Development
Regulatory Affairs
Biosimilars
Biocon Biologics
Board of Directors
Executive Leadership Team
Global Portfolio
Wide Global Footprint
Quality & Compliance
Partners
Global Scale Manufacturing
Research & Development
Branded Formulations
Novel Biologics
Biocon and Novels
Novels Pipeline
Research Services
Investors
Overview
Financial Fact Sheet
Financial Information
Annual Reports
Quarterly Reports
Key Figures (Annual & Quarterly)
Earnings Call Recordings
Earnings Call Transcripts
Subsidiary Financials
Investor Presentations
Corporate Governance
Overview
Board of Directors
Board Committees
Our Leadership
Corporate Structure
Company History & Milestones
Governance Documents & Policies
Share Information
Share Graph
Share Series
Share Price Look Up
Investment Calculator
Share Price Alerts
Fragulizer
Dividends
Unclaimed and Unpaid Dividend
IEPF
Shareholder Services
Annual General Meeting
Postal Ballot
Investor Feedback
Investor FAQ
Miscellaneous Communication
Financial Calendar
Stock Exchange Disclosures
Notice of Board Meeting
Investors Meeting
Press Release
Company Statement
Shareholding Pattern
Corporate Governance Report
Newspaper Advertisement
RPT Disclosure
Other Announcements & Disclosures
Analyst Coverage
Code Of Conduct
Email Subscription Services
Investor Contact
Disclosures under Regulation 46 of LODR
Careers
Overview
Working With Us
Now Hiring
Functions
Our Culture
Diversity And Inclusion
Learning & Development
Awards & Recognition
Benefits
Meet Our Employees
Career FAQ’s
Responsibility
Overview
Biocon Foundation
Social Impact
Partners
Grant-in-Aid
Awards and Recognition
Sustainability
Safer Workplace
An Environment of Change
Environmental Clearance
EHS Certifications
Biocon Academy
News
Overview
Press Releases
Company Statements
Media Stories
Image Gallery
Video Gallery
Events & Calendar
Media Contacts
Resource Center
More+
Contact Us
Blog
For Patients
Biocon in Malaysia
Group Companies
Syngene
Biocon BIologics
Bicara
Biocon Academy
Biocon
/
News
/
Image Gallery
/
Kiran Mazumdar Shaw
Kiran Mazumdar Shaw
Received the fourth-highest civilian award in the Republic of India, the prestigious Padma Shri from the erstwhile President of India Mr R Venkataramanan in 1989
Received the Best Entrepreneur: Healthcare & Life Sciences Award by Ernst & Young in 2002
Received the Business Woman of The Year Award by The Economic Times in 2004.
Received the third-highest civilian award in the Republic of India, the prestigious Padma Bhushan from erstwhile President Dr. APJ Kalam in 2005.
Dr. APJ Abdul Kalam inaugurated Biocon Biopharmaceuticals, India’s largest multi-product Biologics facility at Biocon Park in Bengaluru in 2006.
The launch of India’s first anti-cancer drug BIOMAb EGFR® by Bollywood actor Mr. Shahrukh Khan in 2006.
Received Nikkei Asia Prize for Regional Growth by Japan’s Nihon Keizai Shimbun in 2009
Awarded the Association of Biotechnology Led Enterprises (ABLE) 10th Anniversary Leadership Award in 2013
Awarded the Global Economy Prize for Business by the Kiel Institute for the World Economy, Germany in 2014
Awarded the prestigious Othmer Gold Medal by the Chemical Heritage Foundation, Philadelphia, PA in 2014
Honoured by Federation University, Australia in 2015
Conferred the Global Leadership in Engineering Award for consistent and outstanding contribution to the field of biotechnology by the USC Viterbi School of Engineering in 2016
Appointed ‘Chevalier de l’Ordre National de la Legion d’Honneur’ by the Government of France for outstanding contribution and dedication to the Biosciences and Research field globally in 2016
The Giving Pledge Letter by Ms. Kiran Mazumdar-Shaw displayed at the Smithsonian National Museum of American History in 2019
Conferred with Honorary Doctorate from Deakin University, Australia for her pioneering entrepreneurial role in the field of biotechnology and for her sustained significant contribution to Industry-Academia collaboration between Australia & India in 2019
Received the prestigious EY Entrepreneur of the Year India Award in 2019
Pledges to offer Biocon Biologics’ rh-insulin at USD 0.10 per day to LMICs at UNAIDS Health Innovation Exchange meeting in 2019
Conferred with the Lifetime Achievement Award for Outstanding Achievement in Healthcare by the Indian Council of Medical Research (ICMR) in 2019
Received the EY World Entrepreneur of the Year 2020 (WEOY) at a virtual award ceremony
Elected as a Member of National Academy of Engineering, (NAE), U.S.A., for her contribution to the development of affordable bio-pharmaceuticals and the biotechnology industry in India.
Honoured with the Order of Australia, Australia’s Highest Civilian Honour, in January 2020 for her significant service to advancing Australia’s bilateral relationship with India, particularly in promoting commercial and educational links.
1
/
21